Exact Mass: 650.3795

Thapsigargin

C34H50O12 (650.3302)

Thapsigargin is an organic heterotricyclic compound that is a hexa-oxygenated 6,7-guaianolide isolated fron the roots of Thapsia garganica L., Apiaceae. A potent skin irritant, it is used in traditional medicine as a counter-irritant. Thapsigargin inhibits Ca(2+)-transporting ATPase mediated uptake of calcium ions into sarcoplasmic reticulum and is used in experimentation examining the impacts of increasing cytosolic calcium concentrations. It has a role as an EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor and a calcium channel blocker. It is a sesquiterpene lactone, an organic heterotricyclic compound and a butyrate ester. Thapsigargin is a natural product found in Thapsia gymnesica, Thapsia villosa, and Thapsia garganica with data available. A sesquiterpene lactone found in roots of THAPSIA. It inhibits SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES. C1907 - Drug, Natural Product > C28269 - Phytochemical > C93252 - Sesquiterpene Lactone D004791 - Enzyme Inhibitors (-)-Thapsigargin. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=67526-95-8 (retrieved 2024-11-06) (CAS RN: 67526-95-8). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

Arjunolic acid 3-glucoside

C36H58O10 (650.403)

Arjunolic acid 3-glucoside is found in fruits. Arjunolic acid 3-glucoside is a constituent of Luffa cylindrica (smooth luffa). Constituent of Luffa cylindrica (smooth luffa). Arjunolic acid 3-glucoside is found in fruits.

Lucyoside N

C36H58O10 (650.403)

Lucyoside N is found in fruits. Lucyoside N is a constituent of Luffa cylindrica (smooth luffa). Constituent of Luffa cylindrica (smooth luffa). Lucyoside N is found in fruits.

Esculentoside E

C35H54O11 (650.3666)

Isolated from Phytolacca americana (pokeberry). Esculentoside E is found in fruits and green vegetables. Esculentoside E is found in fruits. Esculentoside E is isolated from Phytolacca americana (pokeberry

Saponin H

C36H58O10 (650.403)

Saponin H is a constituent of Hovenia dulcis (raisin tree) Constituent of Hovenia dulcis (raisin tree)

Digoxigenin bisdigitoxoside

C35H54O11 (650.3666)

Digoxigenin bisdigitoxoside is a metabolite of digoxin. Digoxin is a purified cardiac glycoside and extracted from the foxglove plant, Digitalis lanata. Its corresponding aglycone is digoxigenin, and its acetyl derivative is acetyldigoxin. Digoxin is widely used in the treatment of various heart conditions, namely atrial fibrillation, atrial flutter and sometimes heart failure that cannot be controlled by other medication. Digoxin preparations are commonly marketed under the trade names Lanoxin, Digitek, and Lanoxicaps. (Wikipedia)

3-trans-Caffeoyltormentic acid

C39H54O8 (650.3818)

3-trans-Caffeoyltormentic acid is found in fruits. 3-trans-Caffeoyltormentic acid is a constituent of Eriobotrya japonica (loquat). Constituent of Eriobotrya japonica (loquat). 3-trans-Caffeoyltormentic acid is found in loquat and fruits.

23-trans-p-Coumaroyloxytormentic acid

C39H54O8 (650.3818)

23-cis-p-Coumaroyloxytormentic acid is found in fruits. 23-cis-p-Coumaroyloxytormentic acid is a constituent of Eriobotrya japonica (loquat). Constituent of Eriobotrya japonica (loquat). 23-trans-p-Coumaroyloxytormentic acid is found in loquat and fruits.

Pedunculoside

C36H58O10 (650.403)

Thapsigargin

C34H50O12 (650.3302)

PA(12:0/18:1(12Z)-2OH(9,10))

C33H63O10P (650.4159)

PA(12:0/18:1(12Z)-2OH(9,10)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(12:0/18:1(12Z)-2OH(9,10)), in particular, consists of one chain of one dodecanoyl at the C-1 position and one chain of 9,10-hydroxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:1(12Z)-2OH(9,10)/12:0)

C33H63O10P (650.4159)

PA(18:1(12Z)-2OH(9,10)/12:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-2OH(9,10)/12:0), in particular, consists of one chain of one 9,10-hydroxy-octadecenoyl at the C-1 position and one chain of dodecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(8:0/6 keto-PGF1alpha)

C31H55O12P (650.3431)

PA(8:0/6 keto-PGF1alpha) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/6 keto-PGF1alpha), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of 6-Keto-prostaglandin F1alpha at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(6 keto-PGF1alpha/8:0)

C31H55O12P (650.3431)

PA(6 keto-PGF1alpha/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(6 keto-PGF1alpha/8:0), in particular, consists of one chain of one 6-Keto-prostaglandin F1alpha at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(8:0/TXB2)

C31H55O12P (650.3431)

PA(8:0/TXB2) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/TXB2), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of Thromboxane B2 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(TXB2/8:0)

C31H55O12P (650.3431)

PA(TXB2/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(TXB2/8:0), in particular, consists of one chain of one Thromboxane B2 at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(i-12:0/18:1(12Z)-2OH(9,10))

C33H63O10P (650.4159)

PA(i-12:0/18:1(12Z)-2OH(9,10)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(i-12:0/18:1(12Z)-2OH(9,10)), in particular, consists of one chain of one 10-methylundecanoyl at the C-1 position and one chain of 9,10-hydroxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:1(12Z)-2OH(9,10)/i-12:0)

C33H63O10P (650.4159)

PA(18:1(12Z)-2OH(9,10)/i-12:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-2OH(9,10)/i-12:0), in particular, consists of one chain of one 9,10-hydroxy-octadecenoyl at the C-1 position and one chain of 10-methylundecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Pedunculoside

C36H58O10 (650.403)

Pedunculoside is a natural product found in Ilex chinensis, Ilex excelsa, and other organisms with data available. Pedunculoside exerts lipid-lowering effects partly through the regulation of?lipogenesis?and?fatty acid β-oxidation[1]. Pedunculoside exerts lipid-lowering effects partly through the regulation of?lipogenesis?and?fatty acid β-oxidation[1]. Pedunculoside exerts lipid-lowering effects partly through the regulation of?lipogenesis?and?fatty acid β-oxidation[1].

Rosamultin

C36H58O10 (650.403)

Rosamultin is a 19 α-hydroxyursane-type triterpenoid isolated from Potentilla anserina?L. Rosamultin has inhibitory effects against HIV-1 protease[1]. Rosamultin has the potential for treating H2O2-induced oxidative stress injury through its antioxidant and antiapoptosis effects[2]. Rosamultin is a 19 α-hydroxyursane-type triterpenoid isolated from Potentilla anserina?L. Rosamultin has inhibitory effects against HIV-1 protease[1]. Rosamultin has the potential for treating H2O2-induced oxidative stress injury through its antioxidant and antiapoptosis effects[2].

Bayogenin 3-O-β-D-glucopyranoside

C36H58O10 (650.403)

Bayogenin 3-O-beta-D-glucopyranoside is a natural product found in Dolichos kilimandscharicus, Polygala japonica, and Caryocar glabrum with data available.

Kajiichigoside F1

C36H58O10 (650.403)

kaji-ichigoside F1 is a natural product found in Sanguisorba officinalis, Photinia serratifolia, and other organisms with data available.

SCHEMBL14028927

C36H58O10 (650.403)

Kolokoside A

C36H58O10 (650.403)

MCULE-6340183574

C36H58O10 (650.403)

Myrtucommulone D

C38H50O9 (650.3455)

Sublanceoside B2

C34H50O12 (650.3302)

Kalidiumoside D

C36H58O10 (650.403)

Quadranoside I

C36H58O10 (650.403)

Sutherlandioside C

C36H58O10 (650.403)

Withametelin P

C34H50O12 (650.3302)

Rubuside I

C36H58O10 (650.403)

Quadranoside X

C36H58O10 (650.403)

Nicandrose E

C31H54O14 (650.3513)

Kolokoside C

C36H58O10 (650.403)

Kolokoside D

C36H58O10 (650.403)

scupontin E

C34H50O12 (650.3302)

23-cis-p-Coumaroyloxytormentic acid

C39H54O8 (650.3818)

Arjunglucoside II

C36H58O10 (650.403)

spathodic acid 28-O-beta-glucopyranoside

C36H58O10 (650.403)

2alpha,3alpha,24-trihydroxyurs-12-en-28-oic acid-28-O-beta-D-glucopyranosyl ester|2??,3??,24-Trihydroxyurs-12-en-28-oic acid-28-O-??-D-glucopyranosyl ester

C36H58O10 (650.403)

C39H54O8

C39H54O8 (650.3818)

Pictoside B

C36H58O10 (650.403)

2-(beta-D-glucopyranosyloxy)-3,16,20-trihydroxy-9-methyl-19-norlanosta-5,24-diene-22-one

C36H58O10 (650.403)

Arjunoside I

C36H58O10 (650.403)

3-O-beta-D-Glucopyranosyl-16beta-hydroxy-gratiogenine

C36H58O10 (650.403)

Anchusoside-4

C36H58O10 (650.403)

Mycoticin a

C36H58O10 (650.403)

23-(trans-p-coumaroyloxy)-3beta,6alpha,30-trihydroxyurs-12-en-28-oic acid

C39H54O8 (650.3818)

gagunin M

C36H58O10 (650.403)

20-O-Benzoyl-13-O-dodecanoateingenol

C39H54O8 (650.3818)

DTXSID00950531

C35H54O11 (650.3666)

21-O-??-D-Glucopyranosyl-3??,21??,30-trihydroxyolean-13(18)-en-24-oic acid

C36H58O10 (650.403)

C36H58O10

C36H58O10 (650.403)

Dipuupehedione

C42H50O6 (650.3607)

3beta,6beta,16beta,21beta-tetrahydroxyolean-12-en-23-al 3-O-beta-glucopyranoside

C36H58O10 (650.403)

phaeanthine

C40H46N2O6 (650.3356)

(20R,22R)-14alpha,20,27-trihydroxy-1-oxowitha-5,24-dienolide-3beta-(O-beta-D-glucopyranoside)

C34H50O12 (650.3302)

3beta,21alpha,23-trihydroxyurs-12-en-28-oic acid 21-O-beta-D-glucopyranoside

C36H58O10 (650.403)

Esculentoside B

C35H54O11 (650.3666)

Aplydilactone

C40H58O7 (650.4182)

3beta,5beta,15alpha,19beta,25-pentahydroxy-16,23-dioxo-9,10-seco-9,19-cyclolanosta-5(10),9(11)-diene 3-O-alpha-L-arabinopyranoside|podocarpaside E

C35H54O11 (650.3666)

beta-D-glucopyranosyl 2alpha,3beta,6beta-trihydroxyolean-12-en-28-oate

C36H58O10 (650.403)

2alpha,3beta-dihydroxy-23-beta-D-glucopyranosyloxyolean-12-en-28-oic acid

C36H58O10 (650.403)

Myrtucommulone C

C38H50O9 (650.3455)

28-O-beta-D-glucopyranosyl-2alpha,3alpha,19-trihydoxy-18,19-secours-11,13(18)-dien-28-oic|kakisaponin C

C36H58O10 (650.403)

(14R,17S,20S,22R)-14,17,20-trihydroxy-3beta-(O-beta-D-glucopyranosyl)-1-oxowitha-5,24-dienolide|coagulin L

C34H50O12 (650.3302)

huangqiyenin A

C36H58O10 (650.403)

3-O-beta-D-glucopyranosyl-olean-12-ene-3beta,27,28-triol-29-oic acid

C36H58O10 (650.403)

(3beta,16beta)-3,16-dihydroxypregna-5,20-diene-20-carboxylic acid gamma-lactone 3-O-alpha-L-rhamnopyranosyl(1->2)-beta-D-glucopyranoside|pallidifloside D

C34H50O12 (650.3302)

3-O-beta-D-glucopyranosyl-olean-12-ene-3beta,28,29-triol-27-oic acid

C36H58O10 (650.403)

phuklona sulfate

C36H58O8S (650.3852)

(2alpha,3alpha,21beta)-21-(beta-D-glucopyranosyloxy)-2,3-dihydroxyolean-12-en-28-oic acid

C36H58O10 (650.403)

Phytolaccoside B

C35H54O11 (650.3666)

1beta,2alpha,3beta,19alpha-tetrahydroxyurs-12-ene-28-oate-3-O-beta-D-xylopyranoside

C36H58O10 (650.403)

16-Oxolyclanitin 30-(4-hydroxycinnamoyl)

C39H54O8 (650.3818)

Vicoside B

C36H58O10 (650.403)

28-O-beta-D-glucopyranosyl-3alpha,19,24-trihydoxy-18,19-secours-11,13(18)-dien-28-oic|kakisaponin B

C36H58O10 (650.403)

Rhamnolipid

C32H58O13 (650.3877)

27-O-beta-D-glucopyranosyl viscosalactone B|27-O-beta-D-glucopyranosylviscosalactone B

C34H50O12 (650.3302)

scuteguatemalin

C34H50O12 (650.3302)

29-O-beta-D-glucopyranosyl-3beta,23-dihydroxyolean-12-en-28-oic acid

C36H58O10 (650.403)

glucodiginin

C34H50O12 (650.3302)

15alpha-Hydroxycimicidol 3-O-beta-D-xyloside|15alpha-hydroxycimicidol-3-O-beta-xyloside

C35H54O11 (650.3666)

Suavissimoside F1

C36H58O10 (650.403)

Tyr Lys Val Glu Ile

C31H50N6O9 (650.3639)

Ile Val Glu Lys Tyr

C31H50N6O9 (650.3639)

3-acetyl-3-dodecanoyl-4-(3-methylbutanoyl)sucrose

C31H54O14 (650.3513)

Esculeoside A lacking O27 glucosyl residue

C36H58O10 (650.403)

Arjunetin

C36H58O10 (650.403)

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (4aS,6aR,6aS,6bR,10S,11S,12aS,14bR)-10,11-dihydroxy-12a-(hydroxymethyl)-2,2,6a,6b,9,9-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate is a natural product found in Terminalia alata, Terminalia arjuna, and Potentilla erecta with data available. Arjunetin, isolated from Terminalia arjuna, is an insect feeding-deterrent and growth inhibitor[1]. Arjunetin, isolated from Terminalia arjuna, is an insect feeding-deterrent and growth inhibitor[1].

7,13,17-O-Triacetyl-5-O-(2-methylbutyryl)-3-O-propanoyl-14-oxopremyrsinol

C34H50O12 (650.3302)

C36H58O10_beta-D-Glucopyranose, 1-O-[(2alpha,3beta,5xi,9xi,18xi)-2,3,19-trihydroxy-28-oxours-12-en-28-yl]

C36H58O10 (650.403)

C36H58O10_beta-D-Glucopyranose, 1-O-[(2alpha,3beta,5xi,9xi,18xi,19alpha)-2,3,19-trihydroxy-28-oxoolean-12-en-28-yl]

C36H58O10 (650.403)

C36H58O10_Hexopyranose, 1-O-(3,19,23-trihydroxy-28-oxours-12-en-28-yl)

C36H58O10 (650.403)

C36H58O10_1-O-[(2alpha,3beta,5xi,9xi,18xi)-2,3,23-Trihydroxy-28-oxoolean-12-en-28-yl]-beta-D-glucopyranose

C36H58O10 (650.403)

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1R,2R,4aS,6aS,6bR,10R,11R,12aR)-1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1S,4aR,6aS,6bR,10R,11R,12aR)-1,10,11-trihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

[6-acetyloxy-4-butanoyloxy-3,3a-dihydroxy-3,6,9-trimethyl-8-[(E)-2-methylbut-2-enoyl]oxy-2-oxo-4,5,6a,7,8,9b-hexahydroazuleno[4,5-b]furan-7-yl] octanoate

C34H50O12 (650.3302)

Bayogenin base + O-Hex

C36H58O10 (650.403)

Annotation level-3

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1S,4aR,6aS,6bR,10R,11R,12aR)-1,10,11-trihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate_major

C36H58O10 (650.403)

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1S,4aR,6aS,6bR,10R,11R,12aR)-1,10,11-trihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate_42.7\\%

C36H58O10 (650.403)

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1R,2R,4aS,6aS,6bR,10R,11R,12aR)-1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate_major

C36H58O10 (650.403)

[6-acetyloxy-4-butanoyloxy-3,3a-dihydroxy-3,6,9-trimethyl-8-[(E)-2-methylbut-2-enoyl]oxy-2-oxo-4,5,6a,7,8,9b-hexahydroazuleno[4,5-b]furan-7-yl] octanoate_26.7\\%

C34H50O12 (650.3302)

[6-acetyloxy-4-butanoyloxy-3,3a-dihydroxy-3,6,9-trimethyl-8-[(E)-2-methylbut-2-enoyl]oxy-2-oxo-4,5,6a,7,8,9b-hexahydroazuleno[4,5-b]furan-7-yl] octanoate_major

C34H50O12 (650.3302)

[6-acetyloxy-4-butanoyloxy-3,3a-dihydroxy-3,6,9-trimethyl-8-[(E)-2-methylbut-2-enoyl]oxy-2-oxo-4,5,6a,7,8,9b-hexahydroazuleno[4,5-b]furan-7-yl] octanoate_85.0\\%

C34H50O12 (650.3302)

[6-acetyloxy-4-butanoyloxy-3,3a-dihydroxy-3,6,9-trimethyl-8-[(E)-2-methylbut-2-enoyl]oxy-2-oxo-4,5,6a,7,8,9b-hexahydroazuleno[4,5-b]furan-7-yl] octanoate_16.4\\%

C34H50O12 (650.3302)

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1R,2R,4aS,6aS,6bR,10R,11R,12aR)-1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate_95.9\\%

C36H58O10 (650.403)

[6-acetyloxy-4-butanoyloxy-3,3a-dihydroxy-3,6,9-trimethyl-8-[(E)-2-methylbut-2-enoyl]oxy-2-oxo-4,5,6a,7,8,9b-hexahydroazuleno[4,5-b]furan-7-yl] octanoate_33.0\\%

C34H50O12 (650.3302)

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1S,4aR,6aS,6bR,10R,11R,12aR)-1,10,11-trihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate_16.2\\%

C36H58O10 (650.403)

Digoxigenin bisdigitoxoside

C35H54O11 (650.3666)

D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides

HRLLL

C30H54N10O6 (650.4228)

YKVEI

C31H50N6O9 (650.3639)

IVEKY

C31H50N6O9 (650.3639)

YAELR

C29H46N8O9 (650.3388)

25-O-(2-beta-D-glucopyranosyl-beta-D-glucopyranosyl)-25-hydroxy-11E-eicosenoic acid

C32H58O13 (650.3877)

PG(12:0/15:1(9Z))

C33H63O10P (650.4159)

PG(13:0/14:1(9Z))

C33H63O10P (650.4159)

PG(14:1(9Z)/13:0)

C33H63O10P (650.4159)

PG(15:1(9Z)/12:0)

C33H63O10P (650.4159)

Esculentoside E

C35H54O11 (650.3666)

Saponin H

C36H58O10 (650.403)

3-trans-Caffeoyltormentic acid

C39H54O8 (650.3818)

23-trans-p-Coumaroyloxytormentic acid

C39H54O8 (650.3818)

Arjunolic acid 3-glucoside

C36H58O10 (650.403)

Lucyoside N

C36H58O10 (650.403)

alpha-L-rhamnopyranosyl- alpha-L-rhamnopyranosyl-beta-hydroxydecanoyl-beta-hydroxydecanoic acid

C32H58O13 (650.3877)

PG 27:1

C33H63O10P (650.4159)

OHOHA-PG

C31H55O12P (650.3431)

Mantuoluoside G

C35H54O11 (650.3666)

Mantuoluoside H

C35H54O11 (650.3666)

1-[4-(2-AZEPAN-1-YL-ETHOXY)-BENZYL]-5-BENZYLOXY-2-(4-BENZYLOXY-PHENYL)-3-METHYL-1H-INDOLE

C44H46N2O3 (650.3508)

[5-[2-[tert-butyl(dimethyl)silyl]oxy-3-[2-[tert-butyl(dimethyl)silyl]oxyethyl-ethylamino]propoxy]-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]boronic acid

C32H59BN2O7Si2 (650.3954)

3-((3-CHOLAMIDOPROPYL)DIMETHYLAMMONIO)-&

C32H62N2O9S (650.4176)

D-Leucinamide, N-methyl-D-leucyl-D-valyl-D-phenylalanyl-D-phenylalanyl-

C36H54N6O5 (650.4155)

Metoprolol Fumarate

C34H54N2O10 (650.3778)

C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist

Rhamnolipid 1

C32H58O13 (650.3877)

3beta,6beta,23-trihydroxyolean-12-en-28-oic acid 28-O-beta-D-glucopyranoside

C36H58O10 (650.403)

A triterpenoid saponin that is the monosaccharide derivative of (3beta,6beta)-3,6,23-trihydroxyolean-12-en-28-oic acid. It has been isolated from the stem bark of Kalopanax pictus.

Ethyl (5S,8S,11S,E)-8-benzyl-5-(tert-butoxymethyl)-3,6,9-trioxo-11-(((S)-2-oxopyrrolidin-3-yl)methyl)-1-phenyl-2-oxa-4,7,10-triazatetradec-12-en-14-oate

C35H46N4O8 (650.3315)

quadranoside IV

C36H58O10 (650.403)

alpha-L-rhamnopyranosyl-alpha-L-rhamnopyranosyl-beta-hydroxydecanoyl-beta-hydroxydecanoic acid

C32H58O13 (650.3877)

soyasapogenol A 3-O-beta-glucuronide

C36H58O10 (650.403)

A triterpenoid saponin that is the 3-O-beta-glucuronide of soyasapogenol A.

3-Acetyl-3-lauryl-4-(isovaleryl)sucrose

C31H54O14 (650.3513)

Sucrose 2-acetyl-3-lauroyl-3-isovalerate

C31H54O14 (650.3513)

Sucrose 2-isovaleroyl-3-isodecanoyl-4-isobutanoate

C31H54O14 (650.3513)

[6-acetyloxy-4-butanoyloxy-3,3a-dihydroxy-3,6,9-trimethyl-8-[(Z)-2-methylbut-2-enoyl]oxy-2-oxo-4,5,6a,7,8,9b-hexahydroazuleno[4,5-b]furan-7-yl] octanoate

C34H50O12 (650.3302)

PA(8:0/6 keto-PGF1alpha)

C31H55O12P (650.3431)

PA(6 keto-PGF1alpha/8:0)

C31H55O12P (650.3431)

PA(8:0/TXB2)

C31H55O12P (650.3431)

PA(TXB2/8:0)

C31H55O12P (650.3431)

PA(12:0/18:1(12Z)-2OH(9,10))

C33H63O10P (650.4159)

PA(18:1(12Z)-2OH(9,10)/12:0)

C33H63O10P (650.4159)

PA(i-12:0/18:1(12Z)-2OH(9,10))

C33H63O10P (650.4159)

PA(18:1(12Z)-2OH(9,10)/i-12:0)

C33H63O10P (650.4159)

N-[(3S,9R,10S)-9-[[[(cyclohexylamino)-oxomethyl]-methylamino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-phenylacetamide

C37H54N4O6 (650.4043)

5-[3-[2-[3-(3,8-Diamino-6-phenylphenanthridin-5-ium-5-yl)propylamino]ethylamino]propyl]-6-methylphenanthridin-5-ium-3,8-diamine

C41H46N8+2 (650.3845)

5alpha,6beta,17alpha-trihydroxywithanolide 27-O-beta-D-glucoside

C34H50O12 (650.3302)

2-[[3-hexadecanoyloxy-2-[(E)-5-hydroxy-8-oxooct-6-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H61NO10P+ (650.4033)

[2-hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C31H55O12P (650.3431)

Smgdg O-16:3_6:0

C31H54O12S (650.3336)

Smgdg O-20:3_2:0

C31H54O12S (650.3336)

Smgdg O-18:3_4:0

C31H54O12S (650.3336)

PEtOH 31:6

C36H59O8P (650.3947)

PMeOH 16:3_16:3

C36H59O8P (650.3947)

PMeOH 14:1_18:5

C36H59O8P (650.3947)

PMeOH 16:2_16:4

C36H59O8P (650.3947)

[1-heptanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C36H58O10 (650.403)

[1-pentanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

C36H58O10 (650.403)

[1-nonanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C36H58O10 (650.403)

[1-[(2-heptanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-icos-11-enoate

C33H63O10P (650.4159)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-docos-13-enoate

C33H63O10P (650.4159)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-octanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-nonadec-9-enoate

C33H63O10P (650.4159)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-tetracos-13-enoate

C33H63O10P (650.4159)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-nonanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-octadec-9-enoate

C33H63O10P (650.4159)

[1-[(2-hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-henicos-11-enoate

C33H63O10P (650.4159)

[1-[(2-decanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-heptadec-9-enoate

C33H63O10P (650.4159)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-tridecanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-tetradec-9-enoate

C33H63O10P (650.4159)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-undecanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-hexadec-9-enoate

C33H63O10P (650.4159)

[1-hydroxy-3-[hydroxy-[3-hydroxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxypropan-2-yl] tetradecanoate

C33H63O10P (650.4159)

[1-[(2-dodecanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-pentadec-9-enoate

C33H63O10P (650.4159)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (Z)-henicos-11-enoate

C33H63O10P (650.4159)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] (Z)-nonadec-9-enoate

C33H63O10P (650.4159)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (Z)-octadec-9-enoate

C33H63O10P (650.4159)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (Z)-tetracos-13-enoate

C33H63O10P (650.4159)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (Z)-docos-13-enoate

C33H63O10P (650.4159)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] (Z)-icos-11-enoate

C33H63O10P (650.4159)

[1-decanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-heptadec-9-enoate

C33H63O10P (650.4159)

[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-[(Z)-tridec-9-enoyl]oxypropyl] tetradecanoate

C33H63O10P (650.4159)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (Z)-tetradec-9-enoate

C33H63O10P (650.4159)

[1-phosphonooxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C36H59O8P (650.3947)

[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-phosphonooxypropyl] (9Z,12Z)-heptadeca-9,12-dienoate

C36H59O8P (650.3947)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (Z)-hexadec-9-enoate

C33H63O10P (650.4159)

[1-[(Z)-pentadec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C36H59O8P (650.3947)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] (Z)-pentadec-9-enoate

C33H63O10P (650.4159)

(1-phosphonooxy-3-undecanoyloxypropan-2-yl) (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C36H59O8P (650.3947)

[1-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-undecanoyloxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate

C36H58O10 (650.403)

[(2R)-1-decanoyloxy-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropan-2-yl] (E)-heptadec-9-enoate

C33H63O10P (650.4159)

[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-phosphonooxypropyl] (11E,14E)-heptadeca-11,14-dienoate

C36H59O8P (650.3947)

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoate

C36H59O8P (650.3947)

[(2S)-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-undecanoyloxypropyl] (E)-hexadec-7-enoate

C33H63O10P (650.4159)

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (E)-tetradec-9-enoate

C33H63O10P (650.4159)

[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-tridecanoyloxypropyl] (E)-tetradec-9-enoate

C33H63O10P (650.4159)

[(2S)-2-decanoyloxy-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropyl] (E)-heptadec-9-enoate

C33H63O10P (650.4159)

[(2S)-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-undecanoyloxypropyl] (E)-hexadec-9-enoate

C33H63O10P (650.4159)

[1-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(E)-undec-4-enoyl]oxypropan-2-yl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate

C36H58O10 (650.403)

[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-dodecanoyloxypropyl] (E)-pentadec-9-enoate

C33H63O10P (650.4159)

[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-phosphonooxypropyl] (8E,11E,14E)-heptadeca-8,11,14-trienoate

C36H59O8P (650.3947)

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (E)-hexadec-9-enoate

C33H63O10P (650.4159)

[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-phosphonooxypropyl] (E)-heptadec-7-enoate

C36H59O8P (650.3947)

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (E)-hexadec-7-enoate

C33H63O10P (650.4159)

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-dodecanoyloxypropan-2-yl] (E)-pentadec-9-enoate

C33H63O10P (650.4159)

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoate

C36H59O8P (650.3947)

2-[hydroxy-[2-hydroxy-3-[(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C36H61NO7P+ (650.4185)

2-[[2-acetyloxy-3-[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C36H61NO7P+ (650.4185)

2alpha,3beta,23alpha-trihydroxyurs-12-en-28-oic acid 28-O-beta-D-glucopyranoside

C36H58O10 (650.403)

A triterpenoid saponin that is the carboxylic ester obtained by the formal condensation of the carboxy group of asiatic acid with beta,23alpha-trihydroxyurs-12-en-28-oic acid 28-O-beta-D-glucopyranose. It has been isolated from Juglans sinensis.

phosphatidylserine 26:0(1-)

C32H61NO10P (650.4033)

A 3-sn-phosphatidyl-L-serine(1-) in which the acyl groups at C-1 and C-2 contain 26 carbons in total and 0 double bonds.

2alpha,3beta,23-trihydroxyolean-12-en-28-oic acid 28-O-beta-D-glucopynoside

C36H58O10 (650.403)

A triterpenoid saponin that is the carboxylic ester obtained by the formal condensation of the carboxy group of arjunolic acid with beta-D-glucopyranose. It has been isolated from Juglans sinensis.

MGDG O-27:6;O

C36H58O10 (650.403)

SMGDG O-22:3

C31H54O12S (650.3336)

SQDG 22:2

C31H54O12S (650.3336)

DGMG 16:2

C31H54O14 (650.3513)

SQMG 23:2

C32H58O11S (650.37)

DGGA 25:6;O

C34H50O12 (650.3302)

DGGA 26:5

C35H54O11 (650.3666)

MGGA 27:5

C36H58O10 (650.403)

PA O-18:0/12:2;O3

C33H63O10P (650.4159)

PA O-30:2;O3

C33H63O10P (650.4159)

PA 20:4/12:3;O

C35H55O9P (650.3584)

PA 22:0/7:2;O3

C32H59O11P (650.3795)

PA 22:0/8:1;O2

C33H63O10P (650.4159)

PA 29:2;O3

C32H59O11P (650.3795)

PA 30:1;O2

C33H63O10P (650.4159)

PA 32:7;O

C35H55O9P (650.3584)

PA 11:0_22:6

C36H59O8P (650.3947)

PA 33:6

C36H59O8P (650.3947)

PG O-16:0/11:2;O

C33H63O10P (650.4159)

PG O-18:0/8:3;O2

C32H59O11P (650.3795)

PG O-25:4;O3

C31H55O12P (650.3431)

PG O-26:3;O2

C32H59O11P (650.3795)

PG O-27:2;O

C33H63O10P (650.4159)

PG P-18:0/7:3;O3

C31H55O12P (650.3431)

PG P-18:0/8:2;O2

C32H59O11P (650.3795)

PG P-18:0/9:1;O

C33H63O10P (650.4159)

PG P-18:1/7:2;O3

C31H55O12P (650.3431)

PG P-18:1/8:1;O2

C32H59O11P (650.3795)

PG 18:0/7:3;O2

C31H55O12P (650.3431)

PG 18:1/7:2;O2

C31H55O12P (650.3431)

PG 18:1/8:1;O

C32H59O11P (650.3795)

PG 20:0/6:2;O

C32H59O11P (650.3795)

PG 20:2/5:1;O2

C31H55O12P (650.3431)

PG 22:1/4:1;O

C32H59O11P (650.3795)

PG 26:2;O

C32H59O11P (650.3795)

PG 10:0_17:1

C33H63O10P (650.4159)

PG 11:0_16:1

C33H63O10P (650.4159)

PG 12:0_15:1

C33H63O10P (650.4159)

PG 13:0_14:1

C33H63O10P (650.4159)

PG 23:0/4:1

C33H63O10P (650.4159)

PI O-18:2/4:1

C31H55O12P (650.3431)

PI O-22:3

C31H55O12P (650.3431)

PI P-18:1/4:1

C31H55O12P (650.3431)

PI P-18:1/4:1 or PI O-18:2/4:1

C31H55O12P (650.3431)

PI P-22:2

C31H55O12P (650.3431)

PI P-22:2 or PI O-22:3

C31H55O12P (650.3431)

PEth 30:7;O

C35H55O9P (650.3584)

PEth 31:6

C36H59O8P (650.3947)

PM 31:7;O

C35H55O9P (650.3584)

PM 32:6

C36H59O8P (650.3947)

ST 28:4;O6;GlcA

C34H50O12 (650.3302)

ST 29:3;O5;GlcA

C35H54O11 (650.3666)

ST 28:5;O7;Hex

C34H50O12 (650.3302)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2r,4as,4bs,6as,7r,8s,10as,10br)-8-hydroxy-2-[(3r,4s)-4-hydroxy-3-methylpentyl]-7-(hydroxymethyl)-4a,4b,7,10a-tetramethyl-4,5,6,6a,8,9,10,10b-octahydro-3h-chrysene-2-carboxylate

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (4as,6as,6br,8ar,9r,10r,11r,12ar,12br,14bs)-10,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(2s)-4-{[(2s)-4-[(1r,4ar,5s,6r,8s,8ar)-5-[(2s,3as,6ar)-2h,3h,3ah,6ah-furo[2,3-b]furan-2-yl]-8-(acetyloxy)-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethoxy]-4-oxobutan-2-yl]oxy}-4-oxobutan-2-yl (3s)-3-hydroxybutanoate

C34H50O12 (650.3302)

6-(1-{5,5a-dihydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,5h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-hydroxyethyl)-4-methyl-3-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-5,6-dihydropyran-2-one

C34H50O12 (650.3302)

2'-[3-(2-hydroxy-4-methylpent-3-en-1-yl)-3-methyloxiran-2-yl]-4'b,8',8',10'a-tetramethyl-7'-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-decahydrospiro[oxolane-3,1'-phenanthren]-5-one

C36H58O10 (650.403)

(4as,6as,6br,8ar,9r,10r,11r,12ar,12br,14bs)-10,11-dihydroxy-2,2,6a,6b,9,12a-hexamethyl-9-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C36H58O10 (650.403)

(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,2r,4as,6as,6br,8ar,10r,11r,12ar,12br,14bs)-1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(2's,3s,4'ar,4'br,7's,8'ar,10'ar)-2'-[(2r,3s)-3-[(2r)-2-hydroxy-4-methylpent-3-en-1-yl]-3-methyloxiran-2-yl]-4'b,8',8',10'a-tetramethyl-7'-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-decahydrospiro[oxolane-3,1'-phenanthren]-5-one

C36H58O10 (650.403)

2-{[2-hydroxy-22-(2-hydroxypropan-2-yl)-3,8,8,17,19-pentamethyl-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracosan-9-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H58O10 (650.403)

(3,4,5,6-tetrahydroxyoxan-2-yl)methyl 10,11-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboperoxoate

C36H58O10 (650.403)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 10,11-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylate

C36H58O10 (650.403)

6-[1-(1,3a-dihydroxy-9a,11a-dimethyl-9-oxo-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h,3h,3bh,4h,6h,7h,8h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl)-1-hydroxyethyl]-3,4-dimethyl-5,6-dihydropyran-2-one

C34H50O12 (650.3302)

5,6-dihydroxy-2,16-dimethyl-15-{1-[4-methyl-6-oxo-5-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-2,3-dihydropyran-2-yl]ethyl}-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadecan-3-one

C34H50O12 (650.3302)

(4s,5r,7r,8r,13r,16s,19r,22r)-8-{[(2s,4s,5r,6r)-5-{[(2s,4s,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-7-hydroxy-5,19-dimethyl-15,18,20-trioxapentacyclo[14.5.1.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosa-1(21),10-dien-14-one

C34H50O12 (650.3302)

16-oxolyclanitin 30-(4-hydroxycinnamoyl)

C39H54O8 (650.3818)

{"Ingredient_id": "HBIN001946","Ingredient_name": "16-oxolyclanitin 30-(4-hydroxycinnamoyl)","Alias": "NA","Ingredient_formula": "C39H54O8","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "16365","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

20-epi-16'-decarbomethoxy 19,20-connoduramine

C41H54N4O3 (650.4196)

{"Ingredient_id": "HBIN003397","Ingredient_name": "20-epi-16'-decarbomethoxy 19,20-connoduramine","Alias": "NA","Ingredient_formula": "C41H54N4O3","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25800","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

20-epi-16'-decarbomethoxy-conoduramine

C41H54N4O3 (650.4196)

{"Ingredient_id": "HBIN003398","Ingredient_name": "20-epi-16'-decarbomethoxy-conoduramine","Alias": "NA","Ingredient_formula": "C41H54N4O3","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6884","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

20-o-benzoyl-13-o-dodecanoateingenol

C39H54O8 (650.3818)

{"Ingredient_id": "HBIN003430","Ingredient_name": "20-o-benzoyl-13-o-dodecanoateingenol","Alias": "NA","Ingredient_formula": "C39H54O8","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14447","TCMID_id": "2239","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

21-o-β-d-glucopyranosyl-3β,21α,30-trihydroxy-olean-13(18)-en-24-oicacid

C36H58O10 (650.403)

{"Ingredient_id": "HBIN003588","Ingredient_name": "21-o-\u03b2-d-glucopyranosyl-3\u03b2,21\u03b1,30-trihydroxy-olean-13(18)-en-24-oicacid","Alias": "NA","Ingredient_formula": "C36H58O10","Ingredient_Smile": "CC12CCC3(C(=C1CC(C(C2)OC4C(C(C(C(O4)CO)O)O)O)(C)CO)CCC5C3(CCC6C5(CCC(C6(C)C(=O)O)O)C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "8744","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

2,3,19-trihydroxy-12-ursen-28-oic acid; (2α,3β,19α)-form,28-o-beta-d-galactopyranosyl ester

C36H58O10 (650.403)

{"Ingredient_id": "HBIN003811","Ingredient_name": "2,3,19-trihydroxy-12-ursen-28-oic acid; (2\u03b1,3\u03b2,19\u03b1)-form,28-o-beta-d-galactopyranosyl ester","Alias": "NA","Ingredient_formula": "C36H58O10","Ingredient_Smile": "NA","Ingredient_weight": "650.84","OB_score": "NA","CAS_id": "146356-82-3","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9010","PubChem_id": "NA","DrugBank_id": "NA"}

2,3,24-trihydroxy-12-oleanen-28-oic acid; (2α,3α)-form,28-o-beta-d-glucopyranosyl ester

C36H58O10 (650.403)

{"Ingredient_id": "HBIN003825","Ingredient_name": "2,3,24-trihydroxy-12-oleanen-28-oic acid; (2\u03b1,3\u03b1)-form,28-o-beta-d-glucopyranosyl ester","Alias": "NA","Ingredient_formula": "C36H58O10","Ingredient_Smile": "NA","Ingredient_weight": "650.84","OB_score": "NA","CAS_id": "274673-56-2","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9000","PubChem_id": "NA","DrugBank_id": "NA"}

28-O-β-D-xylopyranosyl-(1 → 3 )-O-α-L-rhamnopyranosyl-(1 → 2)-β-D-glucopyranosyl(1→6 )-β-D-glucopyranoside arjunolic acid

C36H58O10 (650.403)

{"Ingredient_id": "HBIN005081","Ingredient_name": "28-O-\u03b2-D-xylopyranosyl-(1 \u2192 3 )-O-\u03b1-L-rhamnopyranosyl-(1 \u2192 2)-\u03b2-D-glucopyranosyl(1\u21926 )-\u03b2-D-glucopyranoside arjunolic acid","Alias": "NA","Ingredient_formula": "C36H58O10","Ingredient_Smile": "CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)CO)O)O)C)C)C2C1)C)C(=O)OC6C(C(C(C(O6)CO)O)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "39946","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

2α,3α,24-trihydroxyurs-12-en-28-oicacid-28-o-β-d-glucopyranosyl ester

C36H58O10 (650.403)

{"Ingredient_id": "HBIN005177","Ingredient_name": "2\u03b1,3\u03b1,24-trihydroxyurs-12-en-28-oicacid-28-o-\u03b2-d-glucopyranosyl ester","Alias": "NA","Ingredient_formula": "C36H58O10","Ingredient_Smile": "CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)CO)O)O)C)C)C2C1C)C)C(=O)OC6C(C(C(C(O6)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21849","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

2α,3β,19α- trihydroxy ursolic acid

C36H58O10 (650.403)

{"Ingredient_id": "HBIN005199","Ingredient_name": "2\u03b1,3\u03b2,19\u03b1- trihydroxy ursolic acid","Alias": "NA","Ingredient_formula": "C36H58O10","Ingredient_Smile": "CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)O)O)C)C)C2C1(C)O)C)C(=O)OC6C(C(C(C(O6)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "42491","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3-o-benzoyl-13-o-dodecanoateingenol

C39H54O8 (650.3818)

{"Ingredient_id": "HBIN009123","Ingredient_name": "3-o-benzoyl-13-o-dodecanoateingenol","Alias": "NA","Ingredient_formula": "C39H54O8","Ingredient_Smile": "CCCCCCCCCCCC(=O)OC12CC(C34C=C(C(C3(C(C(=CC(C1C2(C)C)C4=O)CO)O)O)OC(=O)C5=CC=CC=C5)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14446","TCMID_id": "2238","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

arjunicacid-28-o-glucoside

C36H58O10 (650.403)

{"Ingredient_id": "HBIN016849","Ingredient_name": "arjunicacid-28-o-glucoside","Alias": "NA","Ingredient_formula": "C36H58O10","Ingredient_Smile": "CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)CO)O)O)C)C)C2C1)C)C(=O)OC6C(C(C(C(O6)CO)O)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14382","TCMID_id": "1735","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

atratoglaucoside a

C34H50O12 (650.3302)

{"Ingredient_id": "HBIN017316","Ingredient_name": "atratoglaucoside a","Alias": "NA","Ingredient_formula": "C34H50O12","Ingredient_Smile": "CC1C(C(CC(O1)OC2C(OC(C(C2OC)O)OC3CCC4(C5CCC6=COC7(C6C(CO7)OC(=O)C5CC=C4C3)C)C)C)O)O","Ingredient_weight": "650.8 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14427","TCMID_id": "1991","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101109728","DrugBank_id": "NA"}

(3e,5e,7z,9z,11e,29e)-14,16,18,20,22,24,26,28-octahydroxy-31-methyl-32-(sec-butyl)-1-oxacyclodotriaconta-3,5,7,9,11,29-hexaen-2-one

C36H58O10 (650.403)

(1r,2r,4as,6as,6br,8ar,10r,11r,12ar,12br,14bs)-10-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-1,11-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O8 (650.3818)

(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,2r,4as,6as,6br,8ar,10r,11r,12ar,12br,14bs)-1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(1s)-1-[(1s,3as,3br,7s,9ar,9bs,11ar)-7-{[(2r,4r,5r,6r)-5-{[(2s,4s,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-3a-hydroxy-9a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl acetate

C36H58O10 (650.403)

(3s,3ar,4s,6s,6ar,7s,8s,9bs)-6-(acetyloxy)-4-(butanoyloxy)-3,3a-dihydroxy-3,6,9-trimethyl-8-[(2-methylbut-2-enoyl)oxy]-2-oxo-4h,5h,6ah,7h,8h,9bh-azuleno[4,5-b]furan-7-yl octanoate

C34H50O12 (650.3302)

(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 10,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (4as,6as,6br,8ar,9s,10r,11r,12ar,12br,14bs)-10,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

3-hydroxy-11-(hydroxymethyl)-4,6a,6b,8a,11,14b-hexamethyl-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,2,3,4a,5,6,7,8,9,10,12,13,14,14a-tetradecahydropicene-4-carboxylic acid

C36H58O10 (650.403)

6-hydroxy-15-(5-hydroxy-6-methyl-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl)-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-4,18-dione

C36H58O10 (650.403)

(3e,5z,7e,9z,11e,29e)-14,16,18,20,22,24,26,28-octahydroxy-31-methyl-32-(sec-butyl)-1-oxacyclodotriaconta-3,5,7,9,11,29-hexaen-2-one

C36H58O10 (650.403)

(1'r,2r,2's,3'r,4'as,6's,6'as,10'r,10'ar,10'bs)-1',6'-bis(acetyloxy)-4'a,6'a,10'b-trimethyl-10'-[(3-methylbutanoyl)oxy]-5''-oxo-octahydrodispiro[oxirane-2,7'-naphtho[2,1-b]pyran-3',3''-oxolan]-2'-yl 3-methylbutanoate

C34H50O12 (650.3302)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 9,10-dihydroxy-8-(hydroxymethyl)-5a,5b,8,11a-tetramethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylate

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,2r,4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-1,10-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(3e,5e,7e,9e,11e,29e)-14,16,18,20,22,24,26,28-octahydroxy-31-methyl-32-(sec-butyl)-1-oxacyclodotriaconta-3,5,7,9,11,29-hexaen-2-one

C36H58O10 (650.403)

(4r,4as,5r,6ar,6br,8ar,10r,11r,12as,14ar,14bs)-5,11-dihydroxy-4-isopropyl-4a,6a,9,9,12a,14a-hexamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,4h,5h,6h,6bh,7h,8h,8ah,10h,11h,12h,14h,14bh-chryseno[1,2-b]pyran-2-one

C36H58O10 (650.403)

n-[1-({[(8e,10e,16z)-3,15,22,24-tetrahydroxy-5-methoxy-14,16-dimethyl-2-azabicyclo[18.3.1]tetracosa-1(24),2,6,8,10,16,20,22-octaen-13-yl]oxy}carbonyl)cyclopropyl]cyclohexanecarboximidic acid

C37H50N2O8 (650.3567)

9-hydroxy-2,4a,7,7,10a,12a-hexamethyl-2-(3-methylbutan-2-yl)-3-oxo-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,4,4b,5,6,6a,8,9,10,12-decahydrochrysene-1-carboxylic acid

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,2r,4as,6ar,6br,8as,10r,11r,12ar,12bs,14bs)-1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

6-[(acetyloxy)methyl]-4,5-dihydroxy-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-3-yl octadecanoate

C32H58O13 (650.3877)

(6r)-6-[(1s)-1-[(1s,3ar,3br,7r,9ar,9bs,11as)-1,3a-dihydroxy-9a,11a-dimethyl-9-oxo-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h,3h,3bh,4h,6h,7h,8h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-hydroxyethyl]-3,4-dimethyl-5,6-dihydropyran-2-one

C34H50O12 (650.3302)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1s,2r,4as,6as,6br,8ar,9s,10s,11r,12ar,12br,14bs)-10,11-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylate

C36H58O10 (650.403)

2-hydroxy-1-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,6,6,9b,11a-pentamethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-10-one

C36H58O10 (650.403)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(2r,3ar,6r,7ar)-1-[(2r)-2-{[(2r)-2-(acetyloxy)-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-3-phenylpropanoyl]-n-(4-carbamimidamidobutyl)-6-hydroxy-octahydroindole-2-carboximidic acid

C34H46N6O7 (650.3428)

4,8,8,12,21,25,25,29-octamethyl-13,30-dioxanonacyclo[17.15.1.1²,¹⁴.0³,¹².0⁴,⁹.0²⁰,²⁹.0²¹,²⁶.0³¹,³⁵.0¹⁸,³⁶]hexatriaconta-1,14,18(36),19(35),31-pentaene-16,17,33,34-tetrone

C42H50O6 (650.3607)

(5e,7e,9e,11z,29e)-14,16,18,20,22,24,26,28-octahydroxy-31-methyl-32-(sec-butyl)-1-oxacyclodotriaconta-3,5,7,9,11,29-hexaen-2-one

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (4as,6as,6br,8r,8ar,9r,10s,12ar,12br,14bs)-8,10-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2s,4as,4br,6as,8s,9r,10as,10br)-8,9-dihydroxy-2-[(3r,4s)-4-hydroxy-3-methylpentyl]-4a,4b,7,7,10a-pentamethyl-4,5,6,6a,8,9,10,10b-octahydro-3h-chrysene-2-carboxylate

C36H58O10 (650.403)

(1s,3r,6s,8r,11s,12s,14s,15r,16r)-14-hydroxy-15-[(2r,5s)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-9-one

C36H58O10 (650.403)

(2s,6s,9r,11r,12s,13r,15r,16r)-2,9,13-trihydroxy-15-[(2r)-6-hydroxy-6-methyl-4-oxoheptan-2-yl]-7,7,12,16-tetramethyl-6-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}tetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),3(8)-dien-14-one

C35H54O11 (650.3666)

10a,13-dihydroxy-6,14-diisopropyl-2,2,4,4,8,8,10,10-octamethyl-12-(2-methylpropanoyl)-6a,14-dihydro-6h-5,11-dioxapentaphene-1,3,7,9-tetrone

C38H50O9 (650.3455)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1s,2r,4as,6as,6br,8ar,9r,10r,11r,12ar,12br,14bs)-10,11-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylate

C36H58O10 (650.403)

[(2r,3s,4s,5r,6r)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl (1r,2r,4as,6as,6br,8ar,10r,11r,12ar,12br,14br)-1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(6r)-6-[(1r)-1-[(1s,3ar,3br,7r,9ar,9bs,11ar)-3a-hydroxy-9a,11a-dimethyl-9-oxo-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,6h,7h,8h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-hydroxyethyl]-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one

C34H50O12 (650.3302)

(3s,4ar,6as,6br,8as,9r,10s,12ar,12br,14br)-10-hydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C36H58O10 (650.403)

(5e,7e,9e,11e,29e)-14,16,18,20,22,24,26,28-octahydroxy-31-methyl-32-(sec-butyl)-1-oxacyclodotriaconta-3,5,7,9,11,29-hexaen-2-one

C36H58O10 (650.403)

(6s,6as,10ar,14r)-10a,13-dihydroxy-6,14-diisopropyl-2,2,4,4,8,8,10,10-octamethyl-12-(2-methylpropanoyl)-6a,14-dihydro-6h-5,11-dioxapentaphene-1,3,7,9-tetrone

C38H50O9 (650.3455)

(1r,3s,6r,8s,11s,12s,15r,16r)-6-hydroxy-15-[(2r,5s)-5-hydroxy-6-methyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-4,18-dione

C36H58O10 (650.403)

10-hydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C36H58O10 (650.403)

(2r)-2-[(1r,2r,3as,3br,7r,8r,9ar,9bs,11ar)-2,7-dihydroxy-3a,6,6,9b,11a-pentamethyl-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-hydroxy-6-methylhept-5-en-3-one

C36H58O10 (650.403)

(1s,2r,5s,6s,7r,9r,11s,12s,15r,16s)-5,6-dihydroxy-2,16-dimethyl-15-[(1s)-1-[(2r)-4-methyl-6-oxo-5-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-2,3-dihydropyran-2-yl]ethyl]-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadecan-3-one

C34H50O12 (650.3302)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,3as,5ar,5br,7r,7ar,9r,10r,11ar,11br,13ar,13br)-7,9,10-trihydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylate

C36H58O10 (650.403)

15-(5,6-dihydroxy-6-methyl-4-oxoheptan-2-yl)-13,18-dihydroxy-7,7,12,16-tetramethyl-6-[(3,4,5-trihydroxyoxan-2-yl)oxy]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadec-10-en-14-one

C35H54O11 (650.3666)

(6s)-6-[(1r)-1-[(1r,3as,3bs,5r,5ar,9ar,9bs,11ar)-5,5a-dihydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,5h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-hydroxyethyl]-4-methyl-3-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-5,6-dihydropyran-2-one

C34H50O12 (650.3302)

2,9,13-trihydroxy-15-(6-hydroxy-6-methyl-4-oxoheptan-2-yl)-7,7,12,16-tetramethyl-6-[(3,4,5-trihydroxyoxan-2-yl)oxy]tetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),3(8)-dien-14-one

C35H54O11 (650.3666)

6-{2-[(1e)-2-(4-{hydroxy[2-(6-oxooxan-2-yl)cyclopropyl]methyl}-5-[(3e,6e)-1-hydroxynona-3,6-dien-1-yl]-2-[(2e,5e)-octa-2,5-dien-1-yl]oxolan-3-yl)ethenyl]cyclopropyl}oxan-2-one

C40H58O7 (650.4182)

(3s,4s,4ar,5r,6ar,6bs,8s,8as,10s,12as,14ar,14br)-5,8,10-trihydroxy-4,6a,6b,8a,11,11,14b-heptamethyl-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4-carbaldehyde

C36H58O10 (650.403)

(4r,4ar,5r,6ar,6br,8as,10r,11r,12as,14as,14bs)-5,11-dihydroxy-4-isopropyl-4a,6a,9,9,12a,14a-hexamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,4h,5h,6h,6bh,7h,8h,8ah,10h,11h,12h,14h,14bh-chryseno[1,2-c]pyran-1-one

C36H58O10 (650.403)

(6r)-6-[(1r,2s)-2-[(1e)-2-[(2r,3s,4r,5s)-4-[(r)-hydroxy[(1r,2r)-2-[(2r)-6-oxooxan-2-yl]cyclopropyl]methyl]-5-[(1s,3z,6z)-1-hydroxynona-3,6-dien-1-yl]-2-[(2z,5z)-octa-2,5-dien-1-yl]oxolan-3-yl]ethenyl]cyclopropyl]oxan-2-one

C40H58O7 (650.4182)

(3z,5z,7e,9e,11e,29e)-14,16,18,20,22,24,26,28-octahydroxy-31-methyl-32-(sec-butyl)-1-oxacyclodotriaconta-3,5,7,9,11,29-hexaen-2-one

C36H58O10 (650.403)

(1r,2r,3s,4ar,4br,6bs,8s,10as,11as,11br,13ar)-3-hydroxy-1-(hydroxymethyl)-8-(methoxycarbonyl)-1,4a,8,11a,11b-pentamethyl-2-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-2h,3h,4h,4bh,5h,6bh,7h,9h,10h,11h,12h,13h,13ah-indeno[2,1-a]phenanthrene-10a-carboxylic acid

C35H54O11 (650.3666)

(3e,5e,7e,9e,11e,29e)-14,16,18,20,22,24,26,28-octahydroxy-32-isopropyl-15,31-dimethyl-1-oxacyclodotriaconta-3,5,7,9,11,29-hexaen-2-one

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,2r,4as,6as,6br,8ar,9r,10s,12ar,12br,14br)-1,10-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

10,11-dihydroxy-2,2,6a,6b,9,12a-hexamethyl-9-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C36H58O10 (650.403)

2-(2,7-dihydroxy-3a,6,6,9b,11a-pentamethyl-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-1-yl)-2-hydroxy-6-methylhept-5-en-3-one

C36H58O10 (650.403)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 10-hydroxy-2,9-bis(hydroxymethyl)-2,6a,6b,9,12a-pentamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2s,4as,4br,6as,7s,8r,10as,10br)-8-hydroxy-2-[(3r,4s)-4-hydroxy-3-methylpentyl]-7-(hydroxymethyl)-4a,4b,7,10a-tetramethyl-4,5,6,6a,8,9,10,10b-octahydro-3h-chrysene-2-carboxylate

C36H58O10 (650.403)

(1r,2s,3as,3bs,7s,9ar,9br,11ar)-2-hydroxy-1-[(2s,5s)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,6,6,9b,11a-pentamethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-10-one

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,2r,4as,6as,6br,8ar,9r,10s,12as,12br,14bs)-1,10-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

[(2r,3s,4s,5r,6r)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl (4as,6as,6br,8ar,10r,11r,12ar,12br,14bs)-10,11-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboperoxoate

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2r,4ar,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,9-bis(hydroxymethyl)-2,6a,6b,9,12a-pentamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1s,4ar,6as,6br,8ar,10r,11r,12ar,12br,14bs)-1,10,11-trihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(2r)-2-[(1r,2r,3as,3br,7r,8s,9as,9br,11ar)-2,7-dihydroxy-3a,6,6,9b,11a-pentamethyl-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-hydroxy-6-methylhept-5-en-3-one

C36H58O10 (650.403)

(4s,5r,7r,8r,16s,19r,22r)-8-{[(2s,4s,5r,6r)-5-{[(2s,4s,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-7-hydroxy-5,19-dimethyl-15,18,20-trioxapentacyclo[14.5.1.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosa-1(21),10-dien-14-one

C34H50O12 (650.3302)

(1s,4ar,4bs,7s,10ar)-1,4a,7-trimethyl-7-(2-{[3,4,5-tris(acetyloxy)-6-[(acetyloxy)methyl]oxan-2-yl]oxy}ethyl)-3,4,4b,5,6,8,10,10a-octahydro-2h-phenanthrene-1-carboxylic acid

C34H50O12 (650.3302)

(6s,6ar,10as,14r)-10a,13-dihydroxy-6,14-diisopropyl-2,2,4,4,8,8,10,10-octamethyl-12-(2-methylpropanoyl)-6a,14-dihydro-6h-5,11-dioxapentaphene-1,3,7,9-tetrone

C38H50O9 (650.3455)

(4as,6as,6br,8ar,9r,10r,11s,12ar,12br,14bs)-11-hydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C36H58O10 (650.403)

(3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,2r,4as,6as,6br,8ar,10r,11r,12ar,12br,14bs)-1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

3-[(3-{[(3s,4s,5r)-4,5-dihydroxy-6-methyl-3-{[(3s,4s,5r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}decanoyl)oxy]decanoic acid

C32H58O13 (650.3877)

5,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C36H58O10 (650.403)

(4as,6as,6br,8as,9r,10r,11s,12ar,12br,14bs)-11-hydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C36H58O10 (650.403)

(3,4,5,6-tetrahydroxyoxan-2-yl)methyl 1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(4r,4as,5r,6ar,6br,8as,10s,11r,12as,14ar,14bs)-5,11-dihydroxy-4-isopropyl-4a,6a,9,9,12a,14a-hexamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,4h,5h,6h,6bh,7h,8h,8ah,10h,11h,12h,14h,14bh-chryseno[1,2-b]pyran-2-one

C36H58O10 (650.403)

1,4a,7-trimethyl-7-(2-{[3,4,5-tris(acetyloxy)-6-[(acetyloxy)methyl]oxan-2-yl]oxy}ethyl)-3,4,4b,5,6,8,10,10a-octahydro-2h-phenanthrene-1-carboxylic acid

C34H50O12 (650.3302)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 8,9-dihydroxy-2-(4-hydroxy-3-methylpentyl)-4a,4b,7,7,10a-pentamethyl-4,5,6,6a,8,9,10,10b-octahydro-3h-chrysene-2-carboxylate

C36H58O10 (650.403)

1',6'-bis(acetyloxy)-4'a,6'a,10'b-trimethyl-10'-[(3-methylbutanoyl)oxy]-5''-oxo-octahydrodispiro[oxirane-2,7'-naphtho[2,1-b]pyran-3',3''-oxolan]-2'-yl 3-methylbutanoate

C34H50O12 (650.3302)

6-[1-(3a-hydroxy-9a,11a-dimethyl-9-oxo-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,6h,7h,8h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl)-1-hydroxyethyl]-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one

C34H50O12 (650.3302)

6,8-dihydroxy-7-[1-(2-hydroxy-3,3,5,5-tetramethyl-4,6-dioxocyclohex-1-en-1-yl)-2-methylpropyl]-9-isopropyl-2,2,4,4-tetramethyl-5-(2-methylpropanoyl)-9h-xanthene-1,3-dione

C38H50O9 (650.3455)

3-hydroxy-1-(hydroxymethyl)-8-(methoxycarbonyl)-1,4a,8,11a,11b-pentamethyl-2-[(3,4,5-trihydroxyoxan-2-yl)oxy]-2h,3h,4h,4bh,5h,6bh,7h,9h,10h,11h,12h,13h,13ah-indeno[2,1-a]phenanthrene-10a-carboxylic acid

C35H54O11 (650.3666)

(3r)-3-{[(3r)-3-{[(2r,3r,4r,5r,6s)-4,5-dihydroxy-6-methyl-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}decanoyl]oxy}decanoic acid

C32H58O13 (650.3877)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (4as,6as,6br,10s,11s,12as,12br,14br)-10,11-dihydroxy-12a-(hydroxymethyl)-2,2,6a,6b,9,9-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,3as,5ar,5br,7ar,8s,9r,10r,11ar,11br,13ar,13br)-9,10-dihydroxy-8-(hydroxymethyl)-5a,5b,8,11a-tetramethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylate

C36H58O10 (650.403)

(3s,4r,4as,6ar,6bs,8as,10r,11s,14ar,14br)-3-hydroxy-11-(hydroxymethyl)-4,6a,6b,8a,11,14b-hexamethyl-10-{[(2s,3r,4r,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,2,3,4a,5,6,7,8,9,10,12,13,14,14a-tetradecahydropicene-4-carboxylic acid

C36H58O10 (650.403)

(1s,2r,4ar,4br,6ar,8r,9r,10as,12as)-9-hydroxy-2,4a,7,7,10a,12a-hexamethyl-2-[(2r)-3-methylbutan-2-yl]-3-oxo-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,4,4b,5,6,6a,8,9,10,12-decahydrochrysene-1-carboxylic acid

C36H58O10 (650.403)

(4ar,5r,6as,6br,8ar,9r,10r,11s,12ar,12br,14bs)-5,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C36H58O10 (650.403)

(4r,4ar,5r,6ar,6br,8ar,10r,11r,12as,14as,14bs)-5,11-dihydroxy-4-isopropyl-4a,6a,9,9,12a,14a-hexamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,4h,5h,6h,6bh,7h,8h,8ah,10h,11h,12h,14h,14bh-chryseno[1,2-c]pyran-1-one

C36H58O10 (650.403)

5,11-dihydroxy-4-isopropyl-4a,6a,9,9,12a,14a-hexamethyl-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,4h,5h,6h,6bh,7h,8h,8ah,10h,11h,12h,14h,14bh-chryseno[1,2-c]pyran-1-one

C36H58O10 (650.403)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 1,10,11-trihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,2r,4as,6as,6br,8ar,10s,11r,12ar,12br,14bs)-1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(1s,3r,6s,8r,12r,13r,15r,16r,18s)-15-[(2r,5r)-5,6-dihydroxy-6-methyl-4-oxoheptan-2-yl]-13,18-dihydroxy-7,7,12,16-tetramethyl-6-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadec-10-en-14-one

C35H54O11 (650.3666)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 8-hydroxy-2-(4-hydroxy-3-methylpentyl)-7-(hydroxymethyl)-4a,4b,7,10a-tetramethyl-4,5,6,6a,8,9,10,10b-octahydro-3h-chrysene-2-carboxylate

C36H58O10 (650.403)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 8,10,11-trihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

5,11-dihydroxy-4-isopropyl-4a,6a,9,9,12a,14a-hexamethyl-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,4h,5h,6h,6bh,7h,8h,8ah,10h,11h,12h,14h,14bh-chryseno[1,2-b]pyran-2-one

C36H58O10 (650.403)

(4as,6as,6br,8ar,9r,10r,11s,12ar,12br,14br)-11-hydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (4as,6as,6br,8ar,9r,10r,11r,12ar,12br)-10,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(3e,5e,7e,9e,11z,29e)-14,16,18,20,22,24,26,28-octahydroxy-31-methyl-32-(sec-butyl)-1-oxacyclodotriaconta-3,5,7,9,11,29-hexaen-2-one

C36H58O10 (650.403)

10-hydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C36H58O10 (650.403)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 7,9,10-trihydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylate

C36H58O10 (650.403)

8-({5-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-4-methoxy-6-methyloxan-2-yl}oxy)-7-hydroxy-5,19-dimethyl-15,18,20-trioxapentacyclo[14.5.1.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosa-1(21),10-dien-14-one

C34H50O12 (650.3302)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2r,4as,4bs,6ar,8s,9r,10as,10br)-8,9-dihydroxy-2-[(3r,4s)-4-hydroxy-3-methylpentyl]-4a,4b,7,7,10a-pentamethyl-4,5,6,6a,8,9,10,10b-octahydro-3h-chrysene-2-carboxylate

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,2r,4as,6as,6br,8ar,10r,11r,12ar,12br,14bs)-1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (4as,6as,6br,8ar,9r,10r,11r,12ar,12br,14bs)-10,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (4as,6as,6br,8r,8ar,10r,11r,12ar,12br,14bs)-8,10,11-trihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,3as,5ar,5br,7ar,8s,9r,10r,11ar,11br,13ar,13bs)-9,10-dihydroxy-8-(hydroxymethyl)-5a,5b,8,11a-tetramethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylate

C36H58O10 (650.403)

1-[(1s,2s,4s,8s,9s,12s,13r,14r,16r)-14-{[(2s,3r,4s,5s)-4,5-dihydroxy-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-16-hydroxy-9,13-dimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosa-6,18-dien-7-yl]ethanone

C34H50O12 (650.3302)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 10,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(3s,9r)-3-hydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C36H58O10 (650.403)

(1r,2s,3r,4ar,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C36H58O10 (650.403)

(3e,5e,7z,9e,11e,29e)-14,16,18,20,22,24,26,28-octahydroxy-31-methyl-32-(sec-butyl)-1-oxacyclodotriaconta-3,5,7,9,11,29-hexaen-2-one

C36H58O10 (650.403)

(2r,3r,4s,5r,6r)-5-hydroxy-2-{[(2s,3s,4r,5r)-4-hydroxy-2,5-bis(hydroxymethyl)-3-{[(2s)-2-methylbutanoyl]oxy}oxolan-2-yl]oxy}-6-(hydroxymethyl)-4-[(2-methylpropanoyl)oxy]oxan-3-yl decanoate

C31H54O14 (650.3513)

(9r)-6,8-dihydroxy-7-[(1s)-1-(2-hydroxy-3,3,5,5-tetramethyl-4,6-dioxocyclohex-1-en-1-yl)-2-methylpropyl]-9-isopropyl-2,2,4,4-tetramethyl-5-(2-methylpropanoyl)-9h-xanthene-1,3-dione

C38H50O9 (650.3455)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,3as,5ar,5br,7r,7ar,9r,10r,11ar,11br,13ar,13bs)-7,9,10-trihydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylate

C36H58O10 (650.403)

6-{2-[2-(4-{hydroxy[2-(6-oxooxan-2-yl)cyclopropyl]methyl}-5-(1-hydroxynona-3,6-dien-1-yl)-2-(octa-2,5-dien-1-yl)oxolan-3-yl)ethenyl]cyclopropyl}oxan-2-one

C40H58O7 (650.4182)

11-hydroxy-9-(hydroxymethyl)-2-(methoxycarbonyl)-2,6a,6b,12a-tetramethyl-9-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C35H54O11 (650.3666)

5,8,10-trihydroxy-4,6a,6b,8a,11,11,14b-heptamethyl-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4-carbaldehyde

C36H58O10 (650.403)

(2r,3r,4s,5r,6r)-2-{[(1s,2r,3s,4r,7r,9s,12r,14s,17r,18r,19r,21r,22s)-2-hydroxy-22-(2-hydroxypropan-2-yl)-3,8,8,17,19-pentamethyl-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracosan-9-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,2r,4as,6as,6br,8ar,9s,10s,12ar,12br,14bs)-1,10-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,2r,4as,6as,6br,8ar,9s,10s,12ar,12br,14br)-1,10-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,2r,4as,6as,6br,10s,11r,12ar,14bs)-1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(3z,5z,7z,9z,11z,29z)-14,16,18,20,22,24,26,28-octahydroxy-32-isopropyl-15,31-dimethyl-1-oxacyclodotriaconta-3,5,7,9,11,29-hexaen-2-one

C36H58O10 (650.403)

14-hydroxy-15-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-9-one

C36H58O10 (650.403)

1-(2-{[2-(acetyloxy)-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-3-phenylpropanoyl)-n-(4-carbamimidamidobutyl)-6-hydroxy-octahydroindole-2-carboximidic acid

C34H46N6O7 (650.3428)

(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (4as,6as,6br,8ar,9r,10r,11r,12ar,12br)-10,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(1s,2r,4ar,4br,6as,8r,9r,10as,12as)-9-hydroxy-2,4a,7,7,10a,12a-hexamethyl-2-[(2r)-3-methylbutan-2-yl]-3-oxo-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,4,4b,5,6,6a,8,9,10,12-decahydrochrysene-1-carboxylic acid

C36H58O10 (650.403)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,8as,12ar,12br,14br)-1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C36H58O10 (650.403)

(6r)-6-[(1r)-1-[(1r,3as,3bs,5r,5ar,9ar,9bs,11as)-5,5a-dihydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,5h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-hydroxyethyl]-4-methyl-3-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-5,6-dihydropyran-2-one

C34H50O12 (650.3302)

(6r)-6-[(1r)-1-[(5r,5ar)-5,5a-dihydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,5h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-hydroxyethyl]-4-methyl-3-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-5,6-dihydropyran-2-one

C34H50O12 (650.3302)

(4as,6as,6br,8ar,9r,10r,11r,12ar,12br,14bs)-11-hydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C36H58O10 (650.403)

(3s,4r,4ar,6ar,6bs,8as,10r,11s,14ar,14br)-3-hydroxy-11-(hydroxymethyl)-4,6a,6b,8a,11,14b-hexamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,2,3,4a,5,6,7,8,9,10,12,13,14,14a-tetradecahydropicene-4-carboxylic acid

C36H58O10 (650.403)